VY-HTT01

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameVY-HTT01

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionHuntingtin inhibitors

TargetsHuntingtin

Therapy Area/IndicationsHuntington Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVoyager Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVoyager Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsHuntington Disease

Other Information

ATC CodeN/A